Author

About

Dr. Shweta Ashok More is a Quality Assurance professional, researcher, and scientific writer with more than five years of experience in pharmaceutical quality systems, regulatory compliance, validation, and research. She holds a Ph.D. in Medicinal Chemistry and an M.Pharm in Quality Assurance, with expertise spanning formulation and quality management systems, data integrity, risk management, and regulatory documentation. She has worked with leading pharmaceutical organizations including Micro Labs Ltd. as Executive – Corporate QA and Pioneer Pharma as QA Officer (API), while also serving as Assistant Professor in Pharmaceutical Quality Assurance at VESCOP and Bharati Vidyapeeth College of Pharmacy, Mumbai. Dr. More is an ISO 9001:2015 Lead Auditor, Lean Six Sigma Black Belt, PMP-certified professional, and Internal Auditor trained in ISO 9001, ISO 14001, and ISO 45001 standards. She has authored peer-reviewed international publications, contributed one book chapter, and is the inventor of two Indian patents in medicinal chemistry. Her research interests include network pharmacology, molecular docking, pharmaceutical quality systems, validation, regulatory compliance, and novel drug discovery.

Experience

• Assistant Professor – Pharmaceutical Quality Assurance VESCOP, Mumbai
• Assistant Professor – Pharmaceutical Quality Assurance Bharati Vidyapeeth College of Pharmacy, Mumbai
• Executive – Corporate Quality Assurance Micro Labs Ltd., Bengaluru
• QA Officer (API) Pioneer Pharma, Mumbai

Professional Certifications

• ISO 9001:2015 Lead Auditor
• Lean Six Sigma Green Belt
• Lean Six Sigma Black Belt
• Internal Auditor (ISO 9001, ISO 14001 & ISO 45001)
• Project Management Professional (PMP)
• Clinical Research Certification (BS Council of Education & Research & GCP Compass UK)

Recognitions

• Presented “Network Pharmacology Approaches in Drug Repurposing” at National Conference on Drug Discovery & Development (Mumbai).
• Poster Presentation on “Novel Anti-Cancer Agents Targeting VEGFR-2” at International Conference on Medicinal Chemistry & Drug Design (Pune).
• Attended FDP on “Emerging Trends in Network Pharmacology” at YBCCP, Aurangabad.
• Poster Presentation on “Herbal Antimicrobial Gel Formulation” at Annual Pharmacy Conference (SNDT University).
• Delivered a talk on “Approach on Network Pharmacology and Real-world Experience” (Karad University).

Research Publications

• Development and Validation of Stability-indicating method for the determination of Pregabalin by RP-HPLC
  International Journal of Advance Research, Ideas and Innovations in Technology (2018)
  View publication
• Targeting small molecules tyrosine kinases by polyphenols: New move towards anti-tumour drug discovery
  Current Drug Discovery Technologies (2019)
  View publication
• Synthesis, biological investigation and docking study of novel chromen derivatives as anticancer agents
  Anti-Cancer Agents in Medicinal Chemistry (2020)
  View publication
• Chemomodulatory effects of Alysicarpus Vaginalis extract via mitochondria-dependent apoptosis and necroptosis in breast cancer
  Nutrition and Cancer (2020)
  View publication
• Exploring molecular network and docking analysis of Osimertinib in cancer cascade: Need for drug repurposing
  Journal of Cancer Science and Research (2020)
  View publication
• A network pharmacology-based approach to explore potential targets of Caesalpinia Pulcherima: An update prototype in drug discovery
  Scientific Reports (Nature) (2020)
  View publication
• Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs
  Virology (Elsevier) (2020)
  View publication
• Evaluation of in vitro anticancer, antimicrobial, and antioxidant activities of new Cu(II) complexes derived from 4(3H)-quinazolinone: Synthesis, crystal structure, and molecular docking studies
  Journal of Molecular Structure (2021)
  View publication
• Alysicarpus Vaginalis bioactives as ESR signaling pathway inhibitor for breast cancer treatment: A network pharmacology approach
  Nutrition and Cancer (2021)
  View publication
• Design and synthesis of N-4-(substituted benzylidene)-N-2-(4-chloropyrimidin-2-yl)-6,7-dimethoxyquinazoline-2,4-diamines as anticancer agents
  Malaysian Journal of Chemistry (2022)
  View publication
• Dual targeting of VEGFR-2 and c-MET kinases via design and synthesis of substituted benzylidene-6-(5-chloropyrimidine-2-yl)-9H-purine-2,6-diamine derivatives as angiogenesis inhibitor
  Rasayan Journal of Chemistry (2022)
  View publication
• Novel Green and Sustainable Materials and Their Applications (book chapter)
  Cambridge Scholars Publishing (2024)
  
• Novel Pyrazole-Chalcone Hybrids: Synthesis and computational insights against breast cancer
  Chemistry & Biodiversity (2024)
  View publication
• Diuretic effect of novel structural analogues of Ethacrynic acid
  ResearchGate
  View publication